MENU
BHVN
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION
Biohaven (BHVN) Ownership - Who owns Biohaven?
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology... Show more
Industry: #Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
215 Church Street
Phone
+1 203 404-0410
Employees
239
Web
https://www.biohavenpharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.1B
P/E Ratio
N/A
Total Cash
485.99M
Projected Growth
N/A
Total Debt
36.58M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
4.76
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
BHVN
Capitalization
2.1B
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
486M
Total Cash/Share
4.76
Total Debt
36.6M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
423M
P/B Ratio
5.71
Cash Flow
N/A
Earnings
-9.28
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.66B
Current Ratio
3.49
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-877.26M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-150.03
Shares Held By Institutions
5.34B
Shares Outstanding - Current
102M
Total Liabilities
192M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-44.980
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of pharmaceutical drugs
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
215 Church Street
Phone
+1 203 404-0410
Employees
239
Web
https://www.biohavenpharma.com